BNP Paribas Financial Markets
JNP

BNP Paribas Financial Markets’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BNP Paribas Financial Markets’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-107
Closed -$733 – 4390
2014
Q2 		$733 Hold
107
– – ﹤0.01% 3516
2014
Q1 		$717 Hold
107
– – ﹤0.01% 2961
2013
Q4 		$707 Buy
+107
New +$729 ﹤0.01% 3892

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BNP Paribas Financial Markets's JNP Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2014, closing a stake of 107 shares — an estimated $733 sold.

BNP Paribas Financial Markets first reported a position in JNP in Q4 2013 and held it in 3 quarters. The position peaked at $733 in Q2 2014. 36 funds tracked by Wall St. Rank hold JNP as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 107 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2014, an estimated $733.
  • BNP Paribas Financial Markets first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $733 in Q2 2014.
  • 36 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.